Borderline Personality Disorders - Epidemiology Forecast - 2032

January 2022 | 60 pages | ID: B742D1527532EN
DelveInsight

Abstracts

This report can be delivered to the clients within 5-7 Business Days

DelveInsight's 'Borderline Personality Disorders - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical and forecasted Borderline Personality Disorders epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Geographies Covered

• The United States
• EU5 (Germany, France, Italy, Spain, and the United Kingdom)
• Japan

Study Period: 2019-2032

Borderline Personality Disorders Understanding

The DelveInsight Borderline Personality Disorders epidemiology report gives a thorough understanding of the Borderline Personality Disorders by including details such as disease definition, symptoms, causes, pathophysiology, and diagnosis. It also provides treatment algorithms and treatment guidelines for Borderline Personality Disorders in the US, Europe, and Japan. The report covers the detailed information of the Borderline Personality Disorders epidemiology scenario in seven major countries (US, EU5, and Japan).

Borderline Personality Disorders Epidemiology Perspective by DelveInsight

The Borderline Personality Disorders epidemiology division provides insights about historical and current patient pool and forecasted trend for every seven major countries. The Borderline Personality Disorders epidemiology data are studied through all possible division to give a better understanding of the Disease scenario in 7MM. The Borderline Personality Disorders epidemiology segment covers the epidemiology data in the US, EU5 countries (Germany, Spain, Italy, France, and the UK), and Japan from 2019 to 2032. It also helps recognize the causes of current and forecasted trends by exploring numerous studies, survey reports and views of key opinion leaders.

Borderline Personality Disorders Detailed Epidemiology Segmentation

The Borderline Personality Disorders epidemiology covered in the report provides historical as well as forecasted Borderline Personality Disorders epidemiology scenario in the 7MM covering the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan from 2019 to 2032.

The DelveInsight Borderline Personality Disorders report also provides the epidemiology trends observed in the 7MM during the study period, along with the assumptions undertaken. The calculated data are presented with relevant tables and graphs to give a clear view of the epidemiology at first sight.

Scope of the Report

• The Borderline Personality Disorders report covers a detailed overview explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
• The Borderline Personality Disorders Epidemiology Report and Model provide an overview of the global trends of Borderline Personality Disorders in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan)
• The report provides insight into the historical and forecasted patient pool of Borderline Personality Disorders in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan
• The report helps recognize the growth opportunities in the 7MM for the patient population
• The report assesses the disease risk and burden and highlights the unmet needs of Borderline Personality Disorders
• The report provides the segmentation of the Borderline Personality Disorders epidemiology

Report Highlights

• 11-year Forecast of Borderline Personality Disorders epidemiology
• 7MM Coverage
• Prevalent and Diagnosed Cases of Borderline Personality Disorders
• Cases of Borderline Personality Disorders by Mutation Types
• Borderline Personality Disorders Cases associated with Clinical Manifestations

KOL views

We interview, KOLs and SME's opinion through primary research to fill the data gaps and validate our secondary research. The opinion helps understand the total patient population and current treatment pattern. This will support the clients in potential upcoming novel treatment by identifying the overall scenario of the indications.

Key Questions Answered

• What will be the growth opportunities in the 7MM with respect to the patient population pertaining to Borderline Personality Disorders?
• What are the key findings pertaining to the Borderline Personality Disorders epidemiology across 7MM and which country will have the highest number of patients during the forecast period (2019-2032)?
• What would be the total number of patients of Borderline Personality Disorders across the 7MM during the forecast period (2019-2032)?
• Among the EU5 countries, which country will have the highest number of patients during the forecast period (2019-2032)?
• At what CAGR the patient population is expected to grow in 7MM during the forecast period (2019-2032)?
• What is the disease risk, burden and unmet needs of Borderline Personality Disorders?
• What are the currently available treatments of Borderline Personality Disorders?

Reasons to buy

The Borderline Personality Disorders Epidemiology report will allow the user to -

• Develop business strategies by understanding the trends shaping and driving the global Borderline Personality Disorders market
• Quantify patient populations in the global Borderline Personality Disorders market to improve product design, pricing, and launch plans
• Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for Borderline Personality Disorders therapeutics in each of the markets covered
• Understand the magnitude of Borderline Personality Disorders population by its epidemiology
• The Borderline Personality Disorders Epidemiology Model developed by DelveInsight is easy to navigate, interactive with dashboards, and epidemiology based with transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over 11-year forecast period using reputable sources

Key Assessments

• Patient Segmentation
• Disease Risk & Burden
• Risk of disease by the segmentation
• Factors driving growth in a specific patient population

Contents

1. KEY INSIGHTS

2. EXECUTIVE SUMMARY OF BORDERLINE PERSONALITY DISORDERS

3. BORDERLINE PERSONALITY DISORDERS: DISEASE BACKGROUND AND OVERVIEW

3.1. Introduction
3.2. Sign and Symptoms
3.3. Pathophysiology
3.4. Risk Factors
3.5. Diagnosis

4. PATIENT JOURNEY

5. EPIDEMIOLOGY AND PATIENT POPULATION

5.1. Epidemiology Key Findings
5.2. Assumptions and Rationale: 7MM
5.3. Epidemiology Scenario: 7MM
  5.3.1. Borderline Personality Disorders Epidemiology Scenario in the 7MM (2019- 2032)
5.4. United States Epidemiology
  5.4.1. Borderline Personality Disorders Epidemiology Scenario in the United States (2019- 2032)
5.5. EU-5 Country-wise Epidemiology
  5.5.1. Germany Epidemiology
    5.5.1.1. Borderline Personality Disorders Epidemiology Scenario in Germany (2019- 2032)
  5.5.2. France Epidemiology
    5.5.2.1. Borderline Personality Disorders Epidemiology Scenario in France (2019- 2032)
  5.5.3. Italy Epidemiology
    5.5.3.1. Borderline Personality Disorders Epidemiology Scenario in Italy (2019- 2032)
  5.5.4. Spain Epidemiology
    5.5.4.1. Borderline Personality Disorders Epidemiology Scenario in Spain (2019- 2032)
  5.5.5. United Kingdom Epidemiology
    5.5.5.1. Borderline Personality Disorders Epidemiology Scenario in the United Kingdom (2019-2032)
5.6. Japan Epidemiology
  5.6.1. Borderline Personality Disorders Epidemiology Scenario in Japan (2019- 2032)

6. TREATMENT ALGORITHM, CURRENT TREATMENT, AND MEDICAL PRACTICES

6.1. Borderline Personality Disorders Treatment and Management
6.2. Borderline Personality Disorders Treatment Algorithm

7. KOL VIEWS

8. UNMET NEEDS

9. APPENDIX

9.1. Bibliography
9.2. Report Methodology

10. DELVEINSIGHT CAPABILITIES

11. DISCLAIMER

12. ABOUT DELVEINSIGHT

*The table of contents is not exhaustive; will be provided in the final report

List Of Tables

LIST OF TABLES

List of Table:
Table 1: Borderline Personality Disorders Epidemiology in 7MM (2019-2032)
Table 2: Borderline Personality Disorders Diagnosed and Treatable Cases in 7MM (2019-2032)
Table 3: Borderline Personality Disorders Epidemiology in the United States (2019-2032)
Table 4: Borderline Personality Disorders Diagnosed and Treatable Cases in the United States (2019-2032)
Table 5: Borderline Personality Disorders Epidemiology in Germany (2019-2032)
Table 6: Borderline Personality Disorders Diagnosed and Treatable Cases in Germany (2019-2032)
Table 7: Borderline Personality Disorders Epidemiology in France (2019-2032)
Table 8: Borderline Personality Disorders Diagnosed and Treatable Cases in France (2019-2032)
Table 9: Borderline Personality Disorders Epidemiology in Italy (2019-2032)
Table 10: Borderline Personality Disorders Diagnosed and Treatable Cases in Italy (2019-2032)
Table 11: Borderline Personality Disorders Epidemiology in Spain (2019-2032)
Table 12: Borderline Personality Disorders Diagnosed and Treatable Cases in Spain (2019-2032)
Table 13: Borderline Personality Disorders Epidemiology in the United Kingdom (2019-2032)
Table 14: Borderline Personality Disorders Diagnosed and Treatable Cases in the United Kingdom (2019-2032)
Table 15: Borderline Personality Disorders Epidemiology in Japan (2019-2032)
Table 16: Borderline Personality Disorders Diagnosed and Treatable Cases in Japan (2019-2032)

List Of Figures

LIST OF FIGURES

List of Figures
Figure 1 Borderline Personality Disorders Epidemiology in 7MM (2019-2032)
Figure 2 Borderline Personality Disorders Diagnosed and Treatable Cases in 7MM (2019-2032)
Figure 3 Borderline Personality Disorders Epidemiology in the United States (2019-2032)
Figure 4 Borderline Personality Disorders Diagnosed and Treatable Cases in the United States (2019-2032)
Figure 5 Borderline Personality Disorders Epidemiology in Germany (2019-2032)
Figure 6 Borderline Personality Disorders Diagnosed and Treatable Cases in Germany (2019-2032)
Figure 7 Borderline Personality Disorders Epidemiology in France (2019-2032)
Figure 8 Borderline Personality Disorders Diagnosed and Treatable Cases in France (2019-2032)
Figure 9 Borderline Personality Disorders Epidemiology in Italy (2019-2032)
Figure 10 Borderline Personality Disorders Diagnosed and Treatable Cases in Italy (2019-2032)
Figure 11 Borderline Personality Disorders Epidemiology in Spain (2019-2032)
Figure 12 Borderline Personality Disorders Diagnosed and Treatable Cases in Spain (2019-2032)
Figure 13 Borderline Personality Disorders Epidemiology in the United Kingdom (2019-2032)
Figure 14 Borderline Personality Disorders Diagnosed and Treatable Cases in the United Kingdom (2019-2032)
Figure 15 Borderline Personality Disorders Epidemiology in Japan (2019-2032)
Figure 16 Borderline Personality Disorders Diagnosed and Treatable Cases in Japan (2019-2032)
*The table of contents is not exhaustive; will be provided in the final report